SMX (Security Matters) Public (SMX) Competitors $6.51 +1.63 (+33.40%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$7.18 +0.67 (+10.29%) As of 08/8/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SMX vs. EKSO, NVOS, HLP, STRCW, ASML, JCI, CARR, BKR, SYM, and BWXTShould you be buying SMX (Security Matters) Public stock or one of its competitors? The main competitors of SMX (Security Matters) Public include Ekso Bionics (EKSO), Novo Integrated Sciences (NVOS), Hongli Group (HLP), Palladyne AI (STRCW), ASML (ASML), Johnson Controls International (JCI), Carrier Global (CARR), Baker Hughes (BKR), Symbotic (SYM), and BWX Technologies (BWXT). These companies are all part of the "machinery" industry. SMX (Security Matters) Public vs. Its Competitors Ekso Bionics Novo Integrated Sciences Hongli Group Palladyne AI ASML Johnson Controls International Carrier Global Baker Hughes Symbotic BWX Technologies Ekso Bionics (NASDAQ:EKSO) and SMX (Security Matters) Public (NASDAQ:SMX) are both small-cap machinery companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, media sentiment, valuation, profitability and analyst recommendations. Which has more risk and volatility, EKSO or SMX? Ekso Bionics has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500. Comparatively, SMX (Security Matters) Public has a beta of -2.57, indicating that its stock price is 357% less volatile than the S&P 500. Do insiders and institutionals hold more shares of EKSO or SMX? 6.4% of Ekso Bionics shares are owned by institutional investors. Comparatively, 15.7% of SMX (Security Matters) Public shares are owned by institutional investors. 6.0% of Ekso Bionics shares are owned by company insiders. Comparatively, 9.4% of SMX (Security Matters) Public shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has preferable earnings and valuation, EKSO or SMX? Ekso Bionics has higher revenue and earnings than SMX (Security Matters) Public. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEkso Bionics$14.65M0.53-$11.33M-$6.64-0.45SMX (Security Matters) PublicN/AN/A-$31.09MN/AN/A Does the media refer more to EKSO or SMX? In the previous week, SMX (Security Matters) Public had 3 more articles in the media than Ekso Bionics. MarketBeat recorded 3 mentions for SMX (Security Matters) Public and 0 mentions for Ekso Bionics. Ekso Bionics' average media sentiment score of 0.00 beat SMX (Security Matters) Public's score of -0.15 indicating that Ekso Bionics is being referred to more favorably in the media. Company Overall Sentiment Ekso Bionics Neutral SMX (Security Matters) Public Neutral Is EKSO or SMX more profitable? SMX (Security Matters) Public has a net margin of 0.00% compared to Ekso Bionics' net margin of -75.66%. SMX (Security Matters) Public's return on equity of 0.00% beat Ekso Bionics' return on equity.Company Net Margins Return on Equity Return on Assets Ekso Bionics-75.66% -86.60% -41.70% SMX (Security Matters) Public N/A N/A N/A Do analysts prefer EKSO or SMX? Ekso Bionics currently has a consensus price target of $562.50, suggesting a potential upside of 18,712.71%. Given Ekso Bionics' stronger consensus rating and higher probable upside, equities analysts clearly believe Ekso Bionics is more favorable than SMX (Security Matters) Public.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ekso Bionics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00SMX (Security Matters) Public 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryEkso Bionics beats SMX (Security Matters) Public on 7 of the 13 factors compared between the two stocks. Get SMX (Security Matters) Public News Delivered to You Automatically Sign up to receive the latest news and ratings for SMX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SMX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMX vs. The Competition Export to ExcelMetricSMX (Security Matters) PublicTechnology Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$3.23M$2.71B$22.33B$9.72BDividend YieldN/A1.58%2.84%4.12%P/E RatioN/A23.3128.1524.76Price / SalesN/A36.4941.1698.43Price / CashN/A46.2227.1558.47Price / Book0.005.715.395.59Net Income-$31.09M$33.88M$198.75M$265.99M7 Day Performance-25.60%10.95%12.01%5.07%1 Month Performance-70.10%8.16%10.46%0.61%1 Year Performance-99.79%50.68%38.08%22.83% SMX (Security Matters) Public Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMXSMX (Security Matters) Public0.2743 of 5 stars$6.51+33.4%N/A-99.8%$3.23MN/A0.00N/ANews CoverageHigh Trading VolumeEKSOEkso Bionics2.4467 of 5 stars$3.21-2.5%$562.50+17,428.8%-98.7%$8.37M$17.92M-0.4860Analyst RevisionNVOSNovo Integrated SciencesN/A$0.00flatN/A-99.9%$65K$13.52M0.00170HLPHongli GroupN/A$0.66+0.2%N/A-56.1%$0.00$14.11M0.00207Gap UpSTRCWPalladyne AIN/A$0.34-6.5%N/A+1,000.0%$0.00N/A0.0070Gap DownHigh Trading VolumeASMLASML4.5132 of 5 stars$690.35-1.3%$923.80+33.8%-16.1%$272.16B$30.59B28.8744,027Positive NewsJCIJohnson Controls International4.6318 of 5 stars$104.25-2.1%$105.17+0.9%+55.8%$68.69B$20.08B30.9794,000Positive NewsOptions VolumeCARRCarrier Global4.9806 of 5 stars$66.16-0.6%$84.47+27.7%+2.6%$56.35B$22.49B14.4348,000Analyst ForecastBKRBaker Hughes4.5804 of 5 stars$43.56+0.1%$51.47+18.2%+23.4%$42.94B$27.83B14.2357,000Positive NewsEx-DividendSYMSymbotic1.9741 of 5 stars$61.67+9.0%$39.87-35.3%+153.9%$36.49B$2.07B-1,547.001,650Trending NewsEarnings ReportAnalyst ForecastInsider TradeGap UpBWXTBWX Technologies3.6179 of 5 stars$179.15+15.9%$137.94-23.0%+83.3%$16.42B$2.70B57.248,700Trending NewsEarnings ReportDividend AnnouncementAnalyst ForecastInsider TradeOptions VolumeAnalyst Revision Related Companies and Tools Related Companies Ekso Bionics Competitors Novo Integrated Sciences Competitors Hongli Group Competitors Palladyne AI Competitors ASML Competitors Johnson Controls International Competitors Carrier Global Competitors Baker Hughes Competitors Symbotic Competitors BWX Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMX) was last updated on 8/10/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SMX (Security Matters) Public Limited Company Please log in to your account or sign up in order to add this asset to your watchlist. Share SMX (Security Matters) Public With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.